Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team
about
High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in GabonHuman fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosisOutbreaks of Ebola virus disease in Africa: the beginnings of a tragic sagaEbola and Marburg hemorrhagic fevers: neglected tropical diseases?Clinical management of filovirus-infected patientsEbola virus antibody prevalence in dogs and human riskWild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001-2003Ecologic and geographic distribution of filovirus diseaseThe 2014–2015 Ebola outbreak in West Africa: Hands OnInvestigating the zoonotic origin of the West African Ebola epidemicEbola virus diseaseEbola haemorrhagic feverDiscovery and Description of Ebola Zaire Virus in 1976 and Relevance to the West African Epidemic During 2013–2016Ebola virus disease and critical illness.A Review of Pediatric Critical Care in Resource-Limited Settings: A Look at Past, Present, and Future DirectionsClinical development of Ebola vaccinesEbolavirus Evolution: Past and PresentOcular Manifestations of Ebola Virus Disease: An Ophthalmologist's Guide to Prevent Infection and PanicThe Role of Cytokines and Chemokines in Filovirus InfectionEffectiveness of Personal Protective Equipment for Healthcare Workers Caring for Patients with Filovirus Disease: A Rapid ReviewEbola: a holistic approach is required to achieve effective management and controlMouse models for filovirus infectionsStructural basis for differential neutralization of ebolavirusesVaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus InfectionsChloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivityTransmission of Ebola viruses: what we know and what we do not knowThe Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic VirusesDiagnosis of Ebola Virus Disease: Past, Present, and FutureTransmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic InfectionExposure Patterns Driving Ebola Transmission in West Africa: A Retrospective Observational StudyPersonal Protective Equipment: Protecting Health Care Providers in an Ebola OutbreakThe face of Ebola: changing frequency of haemorrhage in the West African compared with Eastern-Central African outbreaksAn Ebola virus-centered knowledge baseEbola Virus Imported from Guinea to Senegal, 2014.Ebola Viral Disease in West Africa: A Threat to Global Health, Economy and Political StabilityHow severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalenceRisk posed by the Ebola epidemic to the Pacific islands: findings of a recent World Health Organization assessment.Ebola virus disease: What clinicians in the United States need to know.Insights from clinical research completed during the west Africa Ebola virus disease epidemic.The Ebola outbreak, 2013-2016: old lessons for new epidemics.
P2860
Q21090030-78B7B430-1E8D-4CD6-84DF-1F4DE62ACA5BQ21144780-CE3BA409-5B1D-4A53-9E9B-C9836D18D330Q21245402-98AB7E8C-EC3E-4F30-8642-54213FA19B0DQ21558510-50A5E0FF-8DC1-41A8-842C-E4B0D25EF2E6Q22305518-DD2E5532-C3F6-4B3A-8EBA-7CD0B542868BQ22305651-41726DB0-DFCE-4719-97B1-6590F476018EQ22305652-CF4D37BB-B7BF-4D20-809F-631501BCCEBEQ22305655-7577AC9E-BCD6-4D40-8077-0E457A1152DAQ24049114-3EA96F29-FE4D-48A0-B2C7-6DD630026032Q24286926-761B68F7-A703-4DF3-9B61-F293A9349832Q24563097-EB13D0AD-324B-4AEB-B7A3-0E9205FB9A1BQ24629338-C4607921-DAFD-4621-9E28-FC3BE0BAE182Q25115033-EADF912B-0BCE-446F-B3F2-F5C0654257E6Q26250274-018F23B1-3CE4-4BBF-B3B5-F75251749B01Q26765737-0582CBC3-9E04-41A1-999B-F764A1CD6B31Q26775792-74EF49BA-9D3E-4EEB-AB19-300A7DC6857DQ26777336-76DE7556-E860-4ACD-B565-323640438A05Q26777816-4245F7CF-F260-4079-B62B-D2CFCEDE6E94Q26778003-9294F3DA-9D44-46E6-AD64-492AF845DF32Q26785435-486115DE-99EF-4875-8690-5B8CF1C567A7Q26823792-E586C671-18DC-4081-9CF3-131E8FF1F839Q27011569-998905E6-337D-48A3-BD73-63432B5E1622Q27014910-69CBAF55-9BF8-4ACF-AC5B-92E3F0873C6DQ27485491-397746E6-1974-4000-B4E4-3664E139E206Q28066142-90CC5C88-8D8C-4544-8C2F-3645014B0BB0Q28083565-53822D0B-BDE9-4E29-B789-D6E93583C9F1Q28271798-8A5B3B1A-86F9-4DF7-A918-CA1F418E3205Q28388534-F25D4C21-4870-4CDD-8F1F-17876CFC4420Q28393073-E0F31A74-FD36-4BD1-BB20-F9FA00A00FB4Q28394360-33E0F9A7-CFA7-42FD-BEC5-585694744100Q28394811-F7C6026D-88B4-457D-BD45-55FD60B9660AQ28606458-C2F3E5D2-2047-4A53-88B7-FBB53E2C494BQ28644851-D359D77F-52F4-4220-89F6-219377E5FBA7Q30148645-F53E7AA6-F83C-4EDD-9E75-4B7289DE1039Q30148821-3BF72181-5A70-4AB5-BD61-C2ABBD78B587Q30151580-BA88EA9B-42A7-43EF-A09A-5681104BF8F2Q30202805-2683A312-6E8A-473F-BE24-10261AD189F6Q30203249-E06BFF1C-0F77-482E-812B-E6AFFE56A5C1Q30234590-444D9921-4216-4D33-AE4B-E0F0951B6302Q30234874-9CA779FB-5A56-4270-AC3B-B012574F284C
P2860
Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team
description
im Januar 1978 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в 1978
@uk
name
Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team
@en
Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team
@nl
type
label
Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team
@en
Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team
@nl
prefLabel
Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team
@en
Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team
@nl
P2860
P1476
Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team
@en
P2860
P304
P407
P577
1978-01-01T00:00:00Z